Everything you need to know about the latest CSL dividend

Own CSL shares? Here's the details regarding its latest dividend.

| More on:
Two happy scientists analysing test results.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • CSL shares dip 1.24% to $292.73 during early afternoon trade following the company's FY22 results 
  • The board announced a final dividend of US$1.18 per share 
  • Eligible shareholders will receive payment on 5 October 

The CSL Limited (ASX: CSL) share price is backtracking 1.24% to $292.73 today following the release of the company's full-year results.

The biotherapeutics company reported a mixed performance due to a "difficult global environment."

Nonetheless, the result was in line with expectations, achieving the top end of its guidance.

Here's a look at the CSL's latest dividend that was announced to the market.

CSL maintains full-year dividend

After delivering a net profit after tax (NPAT) of $2,255 million in FY22, the CSL board declared a final dividend of US$1.18 per share.

When converted to the Australian currency, this reflects an approximate dividend of $1.68 per share, franked at 10%.

Moreover, despite CSL maintaining its full-year dividend of US$2.22 apiece, this is 6% higher due to favourable currency movements.

The full-year dividend is equivalent to 46.2% of the group's basic earnings per share (EPS) of US$4.81.

You still have time to scoop up the latest dividend as the ex-dividend date falls on 6 September.

CSL will pay the distribution of its profits to eligible shareholders on 5 October.

What about the FY23 dividend?

While CSL didn't give any guidance on its dividend for FY23, we take a look at what Goldman Sachs had to say.

The broker released its key takeaways on the back of CSL's FY22 results.

It said "NPAT is guided to $2.4bn-2.5bn, excluding Vifor (constant currency terms). Consensus expectations are heavily distorted by the impact of Vifor in our view, but our best guess at 'organic CSL' consensus is $2.575bn."

Upside risks included: More supportive pricing dynamic than we already expect, positive results from pipeline/pre-commercialisation products, and plasma donor fee deflation.

However, downside risks involved: Competitive product launches, challenges associated with unemployment/payer mix, and sustained challenges due to COVID-19.

Goldman Sachs has a neutral rating on CSL with a 12-month target price of $307 per share.

CSL share price snapshot

Over the last 12 months, the CSL share price experienced volatility on the back of an uncertain global economic outlook.

After touching a 52-week low of $240.10 on 15 February, its shares hit resistance at around the $270 mark.

Since then, that barrier has been breached with CSL shares trading around 4% under the psychological $300 level.

Based on today's price, CSL commands a market capitalisation of $141 billion and has a trailing dividend yield of 1.03%.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Dividend Investing

Man pointing an upward line on a bar graph symbolising a rising share price.
Dividend Investing

3 growing ASX dividend stocks to buy now

Analysts are expecting these stock to paying growing dividends.

Read more »

Man holding out $50 and $100 notes in his hands, symbolising ex dividend.
Dividend Investing

Where I'd invest $5,000 into ASX dividend shares right now

These two stocks look irresistible to me.

Read more »

Smiling business woman calculates tax at desk in office.
Dividend Investing

Turn tax return into passive income with these ASX dividend shares

These options can bring solid returns through passive income. 

Read more »

Hand holding Australian dollar (AUD) bills, symbolising ex dividend day. Passive income.
Dividend Investing

Forget term deposits, these ASX dividend shares offer ~5% to 11% yields

Analysts think these shares could be better than term deposits. Let's find out what yields they offer.

Read more »

Tax time written on wooden blocks next to a calculator and Australian dollar notes.
Tax

Tax time: Use this hack to keep the Australian Tax Office off your back

Buying dividend shares can save you paying taxes...

Read more »

Man smiling at a laptop because of a rising share price.
Dividend Investing

2 exciting high-yield ASX dividend shares I'd buy in June

These stocks have a lot to offer investors focused on income.

Read more »

A male investor sits at his desk looking at his laptop screen holding his hand to his chin pondering whether to buy Macquarie shares
Dividend Investing

Looking for passive income amid falling interest rates? Check out this top ASX All Ords dividend stock

This high-yielding ASX dividend stock can help boost your passive income amid falling interest rates.

Read more »

A man sits in deep thought with a pen held to his lips as he ponders his computer screen with a laptop open next to him on his desk in a home office environment.
Dividend Investing

Down 34% since 2021, does this ASX dividend share still offer investors a 10% yield today?

There are a few warning signs over this stock.

Read more »